Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study

Gerhard Kluger; T Glauser; G Krauss; R Seeruthun; C Perdomo; S Arroyo

doi:10.1111/j.1600-0404.2010.01334.x

Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study

Gerhard Kluger^* (First author), T Glauser, G Krauss, R Seeruthun, C Perdomo, S Arroyo

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

90 Citations (Web of Science)

Original language	English
Pages (from-to)	202-208
Journal	ACTA NEUROLOGICA SCANDINAVICA
Volume	122
Issue number	3
DOIs	https://doi.org/10.1111/j.1600-0404.2010.01334.x
Publication status	Published - 2010

Keywords

TRIAL
EFFICACY
TOPIRAMATE
FELBAMATE
EPILEPSY

Access to Document

10.1111/j.1600-0404.2010.01334.x

Cite this

Kluger, G., Glauser, T., Krauss, G., Seeruthun, R., Perdomo, C., & Arroyo, S. (2010). Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study. ACTA NEUROLOGICA SCANDINAVICA , 122(3), 202-208. https://doi.org/10.1111/j.1600-0404.2010.01334.x

Kluger, Gerhard ; Glauser, T ; Krauss, G et al. / Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study. In: ACTA NEUROLOGICA SCANDINAVICA 2010 ; Vol. 122, No. 3. pp. 202-208.

@article{a833637e990e4293b1f59b14dd6a7f0a,

title = "Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study",

keywords = "TRIAL, EFFICACY, TOPIRAMATE, FELBAMATE, EPILEPSY",

author = "Gerhard Kluger and T Glauser and G Krauss and R Seeruthun and C Perdomo and S Arroyo",

year = "2010",

doi = "10.1111/j.1600-0404.2010.01334.x",

language = "English",

volume = "122",

pages = "202--208",

journal = "ACTA NEUROLOGICA SCANDINAVICA ",

issn = "0001-6314",

number = "3",

}

Kluger, G, Glauser, T, Krauss, G, Seeruthun, R, Perdomo, C & Arroyo, S 2010, 'Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study', ACTA NEUROLOGICA SCANDINAVICA , vol. 122, no. 3, pp. 202-208. https://doi.org/10.1111/j.1600-0404.2010.01334.x

Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study. / Kluger, Gerhard (First author); Glauser, T; Krauss, G et al.
In: ACTA NEUROLOGICA SCANDINAVICA , Vol. 122, No. 3, 2010, p. 202-208.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study

AU - Kluger, Gerhard

AU - Glauser, T

AU - Krauss, G

AU - Seeruthun, R

AU - Perdomo, C

AU - Arroyo, S

PY - 2010

Y1 - 2010

KW - TRIAL

KW - EFFICACY

KW - TOPIRAMATE

KW - FELBAMATE

KW - EPILEPSY

U2 - 10.1111/j.1600-0404.2010.01334.x

DO - 10.1111/j.1600-0404.2010.01334.x

M3 - Original Article

C2 - 20199521

SN - 0001-6314

VL - 122

SP - 202

EP - 208

JO - ACTA NEUROLOGICA SCANDINAVICA

JF - ACTA NEUROLOGICA SCANDINAVICA

IS - 3

ER -

Kluger G, Glauser T, Krauss G, Seeruthun R, Perdomo C, Arroyo S. Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study. ACTA NEUROLOGICA SCANDINAVICA . 2010;122(3):202-208. doi: 10.1111/j.1600-0404.2010.01334.x